🇺🇸 FDA
Patent

US 10261094

Competitive ligand binding assay for detecting neutralizing antibodies

granted A61PA61P13/08A61P21/00

Quick answer

US patent 10261094 (Competitive ligand binding assay for detecting neutralizing antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P13/08, A61P21/00, A61P25/28, A61P29/00